131 related articles for article (PubMed ID: 23975297)
1. Axillary surgery among estrogen receptor positive women 70 years of age or older with clinical stage I breast cancer, 2004-2010: a report from the National Cancer Data Base.
Pesce C; Czechura T; Winchester DJ; Huo D; Winchester DP; Yao K
Ann Surg Oncol; 2013 Oct; 20(10):3259-65. PubMed ID: 23975297
[TBL] [Abstract][Full Text] [Related]
2. The Association of Extent of Axillary Surgery and Survival in Women with N2-3 Invasive Breast Cancer.
Park TS; Thomas SM; Rosenberger LH; Fayanju OM; Plichta JK; Blitzblau RC; Ong CT; Hyslop T; Hwang ES; Greenup RA
Ann Surg Oncol; 2018 Oct; 25(10):3019-3029. PubMed ID: 29978365
[TBL] [Abstract][Full Text] [Related]
3. Does a Positive Axillary Lymph Node Needle Biopsy Result Predict the Need for an Axillary Lymph Node Dissection in Clinically Node-Negative Breast Cancer Patients in the ACOSOG Z0011 Era?
Pilewskie M; Mautner SK; Stempel M; Eaton A; Morrow M
Ann Surg Oncol; 2016 Apr; 23(4):1123-8. PubMed ID: 26553439
[TBL] [Abstract][Full Text] [Related]
4. Nodal positivity decreases with age in women with early-stage, hormone receptor-positive breast cancer.
Downs-Canner SM; Gaber CE; Louie RJ; Strassle PD; Gallagher KK; Muss HB; Ollila DW
Cancer; 2020 Mar; 126(6):1193-1201. PubMed ID: 31860136
[TBL] [Abstract][Full Text] [Related]
5. Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer.
Pesce C; Liederbach E; Wang C; Lapin B; Winchester DJ; Yao K
Ann Surg Oncol; 2014 Oct; 21(10):3231-9. PubMed ID: 25081341
[TBL] [Abstract][Full Text] [Related]
6. Axillary Management of Stage II/III Breast Cancer in Patients Treated with Neoadjuvant Systemic Therapy: Results of CALGB 40601 (HER2-Positive) and CALGB 40603 (Triple-Negative).
Ollila DW; Cirrincione CT; Berry DA; Carey LA; Sikov WM; Hudis CA; Winer EP; Golshan M
J Am Coll Surg; 2017 Apr; 224(4):688-694. PubMed ID: 28089784
[TBL] [Abstract][Full Text] [Related]
7. The sensitivity of pre-operative axillary staging in breast cancer: comparison of invasive lobular and ductal carcinoma.
Topps A; Clay V; Absar M; Howe M; Lim Y; Johnson R; Bundred N
Eur J Surg Oncol; 2014 Jul; 40(7):813-7. PubMed ID: 24797703
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment.
Milgrom S; Cody H; Tan L; Morrow M; Pesce C; Setton J; Rogers K; Arnold B; Eaton A; Catalano J; McCormick B; Powell S; Ho A
Ann Surg Oncol; 2012 Nov; 19(12):3762-70. PubMed ID: 22576064
[TBL] [Abstract][Full Text] [Related]
9. Impact of the American College of Surgeons Oncology Group Z0011 Randomized Trial on the Number of Axillary Nodes Removed for Patients with Early-Stage Breast Cancer.
Yao K; Liederbach E; Pesce C; Wang CH; Winchester DJ
J Am Coll Surg; 2015 Jul; 221(1):71-81. PubMed ID: 25899731
[TBL] [Abstract][Full Text] [Related]
10. Lobular Histology Does Not Predict the Need for Axillary Dissection Among ACOSOG Z0011-Eligible Breast Cancers.
Mamtani A; Zabor EC; Stempel M; Morrow M
Ann Surg Oncol; 2019 Oct; 26(10):3269-3274. PubMed ID: 31342363
[TBL] [Abstract][Full Text] [Related]
11. Is axillary lymph node dissection necessary for positive preoperative aspiration cytology lymph node results?
Horváth Z; Paszt A; Simonka Z; Látos M; Kaizer L; Hamar S; Vörös A; Ormándi K; Fejes Z; Lázár G
Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):504-510. PubMed ID: 31708307
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
[TBL] [Abstract][Full Text] [Related]
13. De-escalation of axillary surgery in breast cancer patients treated in the neoadjuvant setting: a Dutch population-based study.
Simons JM; Koppert LB; Luiten EJT; van der Pol CC; Samiei S; de Wilt JHW; Siesling S; Smidt ML
Breast Cancer Res Treat; 2020 Apr; 180(3):725-733. PubMed ID: 32180074
[TBL] [Abstract][Full Text] [Related]
14. Utilization of Axillary Surgery for Patients With Ductal Carcinoma In Situ: A Report From the National Cancer Data Base.
Miller ME; Kyrillos A; Yao K; Kantor O; Tseng J; Winchester DJ; Shulman LN
Ann Surg Oncol; 2016 Oct; 23(10):3337-46. PubMed ID: 27334212
[TBL] [Abstract][Full Text] [Related]
15. Survival analysis of early-stage breast cancer patients undergoing axillary lymph node dissection and sentinel lymph node dissection.
Nayyar A; Strassle PD; Shen MR; Black JA; Gallagher KK; McGuire KP
Am J Surg; 2018 Oct; 216(4):706-712. PubMed ID: 30060915
[TBL] [Abstract][Full Text] [Related]
16. Palliative Local Surgery for Locally Advanced Breast Cancer Depending on Hormone Receptor Status in Elderly Patients.
Pan H; Zhang K; Wang M; Ling L; Zhou W; Wang S
Clin Breast Cancer; 2019 Feb; 19(1):e247-e260. PubMed ID: 30348592
[TBL] [Abstract][Full Text] [Related]
17. Axillary regional recurrence after sentinel lymph node biopsy for breast cancer.
Rosing DK; Dauphine CE; Vargas MP; Gonzalez K; Burla M; Kaufmann P; Vargas HI
Am Surg; 2006 Oct; 72(10):939-42. PubMed ID: 17058740
[TBL] [Abstract][Full Text] [Related]
18. Are there patients with T1 to T2, lymph node-negative breast cancer who are "high-risk" for locoregional disease recurrence?
Mamtani A; Patil S; Stempel MM; Morrow M
Cancer; 2017 Jul; 123(14):2626-2633. PubMed ID: 28334423
[TBL] [Abstract][Full Text] [Related]
19. Identification of women with T1-T2 breast cancer at low risk of positive axillary nodes.
Fein DA; Fowble BL; Hanlon AL; Hooks MA; Hoffman JP; Sigurdson ER; Jardines LA; Eisenberg BL
J Surg Oncol; 1997 May; 65(1):34-9. PubMed ID: 9179265
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of clinically node-negative breast cancer without axillary dissection: can preserved axilla be safely treated with radiation after a positive sentinel node biopsy?
Sanuki N; Takeda A; Amemiya A; Ofuchi T; Ono M; Ogata H; Yamagami R; Hatayama J; Eriguchi T; Kunieda E
Clin Breast Cancer; 2013 Feb; 13(1):69-76. PubMed ID: 23062706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
